FGF21 in human milk
Data are Ct means of FGF21 mRNA (FGF21) and 18S rRNA (18S) RT-PCR amplification of RNA in the conditions described in the methods section (4-6 independent control females or lactating dams per group). Ct >40 are considered undetectable. amplification of RNA in the conditions described in the methods section (2-5 independent samples). Ct >40 are considered undetectable.
Control females

FGF21 18S
Liver (Biopsies) 32,4 13,7
Resting mammary gland (Biopsies) >40 14,3 
Lactating mammary gland (Cells in milk)
Supplemental
Acquisition and analysis of rodent milk
To study the concentration of FGF21 in milk, adult female Swiss mice and Wistar rats were mated with appropriate males. After delivery, all litters were adjusted to 9-10 pups. Milk samples were collected from dams on day 15 of lactation. Nursing dams were separated from their pups for 12 h (to ensure that the mammary glands were full of milk), anesthetized with isoflurane and manually milked. Milk samples were stored frozen at -20ºC. For analysis, each sample was centrifuged (13000 rpm for 10 min at 4ºC) for removal of the fat layer. Blood samples were collected from the end of the tail. The FGF21 protein levels in milk and plasma from mice and rats were determined by ELISA (RD291108200R, BioVendor R&D, BrnoModřice, Czech Republic).
The milk composition was determined as follows. Triglycerides were measured using a commercial kit (Sigma-Aldrich). The protein content was measured by
Bradford method (Bio-Rad Protein Assay; Bio-Rad Laboratories GmbH, Munich, Germany). The lactose content was spectrophotometrically quantified based on the production of NAD by the coupled reactions catalysed by β-galactosidase and glucose/hexokinase-glucose 6-phosphate dehydrogenase (Glucose Assay Reagent) (Sigma-Aldrich, St. Louis, MO). The individual fatty acid composition was determined by gas chromatography using a gas chromatograph/mass spectrometer (Shimadzu GCMS-QP2010 Plus) and a reference FAME mixture (GLC-744 Nu-Chek Prep), essentially following the method described by Lepage Corporation, Billerica, MA).
Measurement of FGF21 in human breast milk
Mature breast milk (sampled at least 1 month after parturition) and blood samples were obtained from donors who voluntarily consented to participate in the study.
The study subjects comprised 22 healthy women between 27 and 37 years of age.
According to the time of lactation, milk samples were divided in colostrum (day 1 to 5 after birth) (n=4), transitional milk (day 6 to 21) (n=4), fully mature milk under 6 months (n=10) and fully mature milk over 6 months (n=4). For analysis of FGF21 analysis, skim milk was prepared by centrifugation of whole milk at 13000 rpm for 10 min at 4ºC. Human FGF21 protein levels in milk and serum were determined by ELISA (RD191108200R, BioVendor R&D). This portion of the study was approved
by Bioethics Committee at the University of Barcelona, Spain.
Expression analysis in human mammary gland
Two commercial resting mammary gland RNA samples were obtained from a 27-year-old sudden dead Caucasian female (Clontech Laboratories, Inc.; Ref.
636576) and from a single healthy normal donor (AMS Biotechnology; Ref. . Lactating mammary gland RNA was obtained from cells present in 5 fresh milk samples, following a previously described method (28). Milk samples were collected using a manual pump under aseptic conditions, stored at 4 ºC, and processed within 6 hours after expression. Briefly, milk samples were diluted with PBS 1x (1:1), centrifuged at 800 xg for 20 min at room temperature, and upper fat layer and serum phase were removed. Cell pellets were washed twice with PBS 1x
and RNA was purified as described in the below section "RNA isolation, cDNA synthesis, and real-time PCR". Three liver samples obtained from biopsies were used as positive controls of FGF21 expression. In both cases, informed consent from all subjects were obtained and the study was approved by the Bioethics
Committee at the University of Barcelona, Spain.
Studies in lactating mice
Lactating dams (days 4, 8, 15 and 21 after delivery) and virgin female mice of the same age (controls) were sacrificed by decapitation. Blood was collected, plasma was obtained, and mammary gland, liver, periovaric WAT and interscapular BAT were dissected and frozen in liquid nitrogen for further analysis. 
Studies in neonatal mice and animal experimental designs
For studies in neonatal development, C57/BL6 pups were studied 2, 8 and/or 15 days after birth. When indicated, we used FGF21-/-(FGF21-KO) mice (B6N;129S5-Fgf21tm1Lex/Mmcd; obtained from the Mutant Mouse Regional
Resource Centre, an NCRR-NIH-funded strain repository, and donated to the MMRRC by Genentech) that had been backcrossed to C57/BL6 background (27).
Pups were killed by decapitation; blood was collected for preparation of serum; and tissues were immediately frozen in liquid nitrogen, and stored at -80ºC until 13 processing. For comparison, tissues were also obtained from adult mice (male, 5 month-old).
To study the specific localization of β-Klotho expression in the intestinal mucosa, small intestines were removed from 15 day-old lactating mice. Samples of the duodenum, jejunum and ileum were cut longitudinally to expose the luminal areas, and a blade was used to scrape the mucosa and separate it from the rest of the tissue, following the previously reported procedure (15). Unprocessed tissue (total), mucosa and tissue remaining after scraping were frozen for RNA isolation and gene expression analysis.
For cross-feeding experiments, WT or FGF21-KO adult mice were simultaneously mated with the appropriate males, and the presence of vaginal plugs (indicating pregnancy) was monitored in order to obtain simultaneous WT and KO deliveries. At birth, the litter sizes were adjusted to 7 or 8 individuals and pups were interchanged with dams; a maximum 12-h variability in delivery time was allowed. The experimental groups consisted of WT pups fed by WT dams, KO pups fed by KO dams and KO pups fed by WT dams and WT pups fed by KO dams. All litters were fed by a non-progenitor dam even when maternal and neonatal genotypes were the same. After 8 days of lactation, pups were killed by decapitation, blood was collected, plasma was obtained, and tissues were collected and frozen for further processing. Blood glycemia was determined using 
Intestinal explant incubation
Jejunum samples were collected from 8 day-old pups, divided into 0.5 cm sections, cut longitudinally to expose the mucosa, and incubated with DMEM with or without 10 nM mouse recombinant FGF21 (RD272108100, BioVendor R&D) at 37 °C in a humidified 95% air/5% CO 2 incubator. At the indicated times (10 min, 20 min and 3h), tissue and media samples were collected together and centrifuged, and pellets were frozen for subsequent RNA isolation (for gene expression studies) or protein homogenization (for Western blot analysis).
RNA isolation, cDNA synthesis, and real-time PCR
Dissected tissues were homogenized using an IKA ® T25 digital ULTRA-TURRAX (Staufen, Germany), and total RNA was isolated using a column-affinity based methodology (NucleoSpin RNA II; Macherey-Nagel, Düren, Germany). Total RNA was isolated from rodent samples (tissues, scraped intestinal mucosa, and intestine explants), as well as from cells that had been isolated from human breastmilk using a previously described method (28). Independent samples of total RNA from human mammary gland were obtained from Clontech and AMS Biotechnology. Total RNA (500 ng) was transcribed to cDNA using Multiscribe reverse transcriptase and random-hexamer primers ( 
Immunohistochemical detection of β-Klotho
During tissue collection, intestinal segments were fixed with 4% formalin for 24 h and then stored in ethanol 70% at 4 ºC until paraffin infiltration was performed.
Paraffin-embedded tissues were sectioned to obtain transverse and longitudinal orientations, and the sections were mounted on glass slides. The samples were incubated with an anti-β-Klotho antibody (LS-B3568, LSBio, LifeSpan BioSciences Inc., Seattle, WA) in a humidified chamber overnight at 4 ºC and then incubated with an ABC-complex-conjugated secondary antibody, and the results were visualized with DAB. Finally, samples were stained with hematoxylin and photographed under a microscope (50x magnification).
Quantification of intestinal peptides in plasma
The concentrations of glucagon-like peptide 1 (GLP-1), gastric inhibitory peptide (GIP) and peptide YY (PYY) in plasma samples from the various pups were determined by MILLIPLEX ® MAP Mouse Metabolic Disease Multiplex Assay (Cat.
No. MMHMAG-44K, Millipore).
Lactase activity
Lactase activity was assessed with a slight modification of the method reported by Dahlqvist (29) . Approximately 25 mg of duodenum, jejunum or ileum were homogenized in 6 volumes of NaCl 0,9%. The homogenates were incubated with 4 volumes of 150 mM lactose in 0,1 M maleate buffer (pH 6,5) supplemented with 0,2 mM of the protease inhibitor, 4-chloromercuribenzoic acid, for 20 minutes at 37 ºC. The reaction was stopped with 6% perchloric acid, and samples were centrifuged at maximal speed. The pellet was removed, the supernatant was neutralized with 30% KOH, and the glucose concentration was determined with the Glucose Assay Reagent (Sigma-Aldrich). Enzymatic activity was normalized with respect to the quantity of input protein.
